Silco Pharmaceuticals Ltd

DHA:SILCOPHL (Bangladesh)   Ordinary Shares
BDT 17.30 (+0.58%) Apr 23
Market Cap:
BDT - ($ -)
Enterprise V:
BDT - ($ -)
Volume:
202.98K
Avg Vol (2M):
151.69K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Silco Pharmaceuticals Ltd ( ) from 2019 to Apr 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Silco Pharmaceuticals stock (DHA:SILCOPHL) PE ratio as of Apr 23 2024 is 9999. More Details

Silco Pharmaceuticals Ltd (DHA:SILCOPHL) PE Ratio (TTM) Chart

To

Silco Pharmaceuticals Ltd (DHA:SILCOPHL) PE Ratio (TTM) Historical Data

Total 0
  • 1
Silco Pharmaceuticals PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data

Silco Pharmaceuticals Ltd (DHA:SILCOPHL) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Silco Pharmaceuticals Ltd

ISIN : BD0495SILCO6

Share Class Description:

DHA:SILCOPHL: Ordinary Shares
Compare
Compare
Traded in other countries / regions
SILCOPHL.Bangladesh
IPO Date
2019-06-13
Description
Silco Pharmaceuticals Ltd is engaged in manufacturing and marketing of pharmaceuticals finished products in the categories of Antibiotics, Analgesics, Anti diabetics, Narcotics, Antipyratics, Anti-inflammatory Drugs, Antiulcerants, Multi medicines which are sold mainly in local market.